Merck KGaA (ETR:MRK)

Revenue

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Jun 30, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Process Solutions Revenue	4.00B	3.52B	3.78B
Life Science Services Revenue	-	721.80M	792.20M
Science & Lab Solutions Revenue	-	4.67B	4.71B
Total Life Science Revenue	9.17B	8.92B	9.28B
Oncology Revenue	-	2.01B	1.82B
Neurology & Immunology Revenue	-	1.69B	1.67B
Specialty Care Revenue	3.43B	3.70B	3.48B
Fertility Revenue	-	1.53B	1.55B
Cardiovascular, Metabolism and Endocrinology Revenue	-	2.95B	2.79B
Other Healthcare Revenue	306.90M	280.50M	235.40M
Total Healthcare Revenue	8.59B	8.45B	8.05B
Optronics Revenue	751.80M	748.30M	769.60M
Semiconductor Solutions Revenue	2.57B	2.63B	2.48B
Surface Solutions Revenue	-	406.50M	410.90M
Total Electronics Revenue	3.37B	3.79B	3.66B
Revenue (Other)	-13.76B	-8.45B	-8.05B
Revenue (Total)	21.13B	21.16B	20.99B

Revenue by Geography

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Jun 30, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Europe Revenue	6.52B	6.17B	6.04B
North America Revenue	5.48B	5.71B	5.95B
Asia Pacific Revenue	6.94B	7.02B	6.94B
Latin America Revenue	1.47B	1.48B	1.33B
Middle East & Africa Revenue	735.70M	781.20M	737.10M
Revenue (Other)	100.00K	300.00K	-
Revenue (Total)	21.13B	21.16B	20.99B

EBITDA

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Jun 30, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Life Science EBITDA	2.66B	2.59B	2.82B
Healthcare EBITDA	2.97B	2.99B	2.54B
Electronics EBITDA	980.80M	969.60M	913.00M
Corporate/Others EBITDA	-371.10M	-481.80M	-396.70M
Operating Income (Other)	-2.85B	-2.43B	-2.27B
Operating Income (Total)	3.39B	3.65B	3.61B

Data Source: Fiscal.ai Last updated: Aug 6, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 22, 2026

Data Sources Report a data error